カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の浮腫臨床試験市場2023-2030：フェーズ別（第I相、第II相、第III相、第IV相）、患者別（小児科、成人、高齢者）、スポンサー別、タイプ別、地域別

【英語タイトル】Edema Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Participant (Pediatrics, Adults, Geriatrics), By Sponsor, By Type, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV015）・商品コード：GRV23NOV015
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：175
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

浮腫臨床試験市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の浮腫臨床試験市場規模は2030年までに12.7億米ドルに達し、予測期間中のCAGRは5.71%を記録する見込みです。この市場を牽引しているのは、浮腫に関連する疾患や病態の有病率の上昇、医学研究や技術の進歩、臨床試験実施に対する規制当局の支援やインセンティブの拡大です。様々な地域の政府や保健当局は、承認プロセスを合理化し、浮腫を含むアンメットメディカルニーズのある分野の研究を促進する政策を実施しています。

COVID-19の大流行は臨床試験市場に大きな影響を及ぼし、研究活動を混乱させ、医学研究の状況を一変させました。COVID-19の大流行により、ウイルスと闘うための医療資源が急務となり、浮腫関連疾患を含む多くの進行中の臨床試験が中止されました。さらに、COVID-19の研究は、他の医療分野からの資金流用も招き、研究を継続するためのリソースを求める研究者に困難をもたらしました。

一方、戦略的な取り組みや製品の上市など、市場参入企業によるいくつかの取り組みが市場の成長にさらに貢献しています。例えば、2023年6月、Eyebiotech Limited（EyeBio）は、糖尿病黄斑浮腫および新生血管加齢黄斑変性患者を対象としたRestoretのフェーズ1b/2臨床試験の開始を発表しました。同様に、2021年8月、Novartisは、糖尿病黄斑浮腫を対象としたBeovuの第III相臨床試験で、投与間隔が16週間となるなど良好な結果が得られたと発表しました。

浮腫臨床試験市場レポートハイライト

- 第II相臨床試験セグメントが2022年に約35.71%のシェアで市場を支配しました。第II相臨床試験は、浮腫関連疾患に対する新規治療法の安全性と予備的有効性を評価するために極めて重要です。

- 参加者別では、成人セグメントが2022年の市場を支配しました。このセグメントの成長は、心不全、腎臓病、静脈不全などの基礎疾患を発症する可能性が高く、浮腫の発症に寄与する可能性がある成人の増加によるものです。

- スポンサー別では、製薬会社が最先端の研究所へのアクセスや医薬品開発における専門知識など、広範な研究開発能力を有しているため、2022年の市場シェアは製薬会社が最も高くなっています。

- タイプ別では、疾患有病率の増加、アンメット・メディカル・ニーズ、研究資金の利用可能性に起因して、局所性浮腫セグメントが2022年の市場で圧倒的なシェアを占めました。

- 地域別では、北米が2022年の市場で約41.44%と最も高いシェアを占めています。これは、同地域の高度な医療インフラ、複数の大手製薬企業の存在、および規制環境の支援によるものです。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 市場変数・傾向・範囲
第4章 世界の浮腫臨床試験市場：フェーズ別ビジネス分析
第5章 世界の浮腫臨床試験市場：患者別ビジネス分析
第6章 世界の浮腫臨床試験市場：スポンサー別ビジネス分析
第7章 世界の浮腫臨床試験市場：タイプ別ビジネス分析
第8章 世界の浮腫臨床試験市場：地域別ビジネス分析
第9章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. Porter’s Five Forces Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Phase Business Analysis
4.1. Edema Clinical Trials Market: Phase Movement Analysis, 2022 & 2030
4.2. Phase I
4.2.1. Phase I Market, 2018 – 2030 (USD Million)
4.3. Phase II
4.3.1. Phase II Market, 2018 – 2030 (USD Million)
4.4. Phase III
4.4.1. Phase III Market, 2018 – 2030 (USD Million)
4.5. Phase IV
4.5.1. Phase IV Market, 2018 – 2030 (USD Million)
Chapter 5. Participant Business Analysis
5.1. Edema Clinical Trials Market: Participant Movement Analysis, 2022 & 2030
5.2. Pediatrics
5.2.1. Pediatric Market, 2018 – 2030 (USD Million)
5.3. Adults
5.3.1. Adults Market, 2018 – 2030 (USD Million)
5.4. Geriatrics
5.4.1. Geriatrics Market, 2018 – 2030 (USD Million)
Chapter 6. Sponsor Business Analysis
6.1. Edema Clinical Trials Market: Sponsor Movement Analysis, 2022 & 2030
6.2. Pharmaceutical Companies
6.2.1. Pharmaceutical Companies Market, 2018 – 2030 (USD Million)
6.3. Academic Institutions
6.3.1. Academic Institutions Market, 2018 – 2030 (USD Million)
6.4. Government Bodies
6.4.1. Government Bodies Market, 2018 – 2030 (USD Million)
Chapter 7. Type Business Analysis
7.1. Edema Clinical Trials Market: Type Movement Analysis, 2022 & 2030
7.2. Systemic Edema
7.2.1. Systemic Edema Market, 2018 – 2030 (USD Million)
7.3. Localized Edema
7.3.1. Localized Edema Market, 2018 – 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Competitive Scenario
8.2.3. Canada
8.2.3.1. Canada Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Competitive Scenario
8.3. Europe
8.3.1. Europe Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.3.2. Germany
8.3.2.1. Germany Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Competitive Scenario
8.3.3. UK
8.3.3.1. UK Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Competitive Scenario
8.3.4. France
8.3.4.1. France Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Competitive Scenario
8.3.5. Italy
8.3.5.1. Italy Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Competitive Scenario
8.3.6. Spain
8.3.6.1. Spain Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Competitive Scenario
8.3.7. Denmark
8.3.7.1. Denmark Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Competitive Scenario
8.3.8. Sweden
8.3.8.1. Sweden Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Competitive Scenario
8.3.9. Norway
8.3.9.1. Norway Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Competitive Scenario
8.4. Asia Pacific
8.4.1. Asia Pacific Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Competitive Scenario
8.4.3. China
8.4.3.1. China Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Competitive Scenario
8.4.4. India
8.4.4.1. India Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Competitive Scenario
8.4.5. South Korea
8.4.5.1. South Korea Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Competitive Scenario
8.4.6. Australia
8.4.6.1. Australia Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Competitive Scenario
8.4.7. Thailand
8.4.7.1. Thailand Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Competitive Scenario
8.5. Latin America
8.5.1. Latin America Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.5.2.2. Key Country Dynamics
8.5.2.3. Regulatory Framework
8.5.2.4. Competitive Scenario
8.5.3. Mexico
8.5.3.1. Mexico Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.5.3.2. Key Country Dynamics
8.5.3.3. Regulatory Framework
8.5.3.4. Competitive Scenario
8.5.4. Argentina
8.5.4.1. Argentina Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.5.4.2. Key Country Dynamics
8.5.4.3. Regulatory Framework
8.5.4.4. Competitive Scenario
8.6. MEA
8.6.1. MEA Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Competitive Scenario
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Competitive Scenario
8.6.5. Kuwait
8.6.5.1. Kuwait Edema Clinical Trials Market, 2018 – 2030 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Competitive Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. Acquisition
9.2.2. Collaborations
9.2.3. New Platform Launches
9.2.4. Others
9.3. Company Profiles/Listing
9.3.1. Otsuka Holdings
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Platform Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Hoffmann-La Roche
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Platform Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Novartis Pharmaceuticals
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Platform Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Bayer
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Platform Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Genentech, Inc
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Platform Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Biogen
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Platform Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Johnson & Johnson
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Platform Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Merck & Co., Inc.
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Platform Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Sanofi S.A.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Platform Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. AstraZeneca plc
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Platform Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Bristol Myers Squibb Company
9.3.11.1. Company Overview
9.3.11.2. Financial Performance
9.3.11.3. Platform Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. GlaxoSmithKline plc
9.3.12.1. Company Overview
9.3.12.2. Financial Performance
9.3.12.3. Platform Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. AbbVie Inc.
9.3.13.1. Company Overview
9.3.13.2. Financial Performance
9.3.13.3. Platform Benchmarking
9.3.13.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Global Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 4 Global Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 5 Global Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 6 Global Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 7 Global Edema Clinical Trial Market by Region, 2018 - 2030 (USD Million)
Table 8 North America Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
Table 9 North America Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 10 North America Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 11 North America Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 12 North America Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 13 U.S. Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 14 U.S. Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 15 U.S. Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 16 U.S. Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 17 Canada Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 18 Canada Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 19 Canada Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 20 Canada Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 21 Europe Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
Table 22 Europe Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 23 Europe Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 24 Europe Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 25 Europe Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 26 Germany Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 27 Germany Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 28 Germany Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 29 Germany Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 30 UK Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 31 UK Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 32 UK Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 33 UK Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 34 France Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 35 France Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 36 France Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 37 France Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 38 Italy Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 39 Italy Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 40 Italy Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 41 Italy Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 42 Spain Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 43 Spain Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 44 Spain Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 45 Spain Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 46 Denmark Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 47 Denmark Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 48 Denmark Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 49 Denmark Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 50 Sweden Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 51 Sweden Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 52 Sweden Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 53 Sweden Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 54 Norway Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 55 Norway Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 56 Norway Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 57 Norway Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 63 China Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 64 China Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 65 China Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 66 China Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 67 Japan Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 68 Japan Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 69 Japan Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 70 Japan Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 71 India Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 72 India Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 73 India Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 74 India Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 75 South Korea Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 76 South Korea Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 77 South Korea Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 78 South Korea Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 79 Australia Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 80 Australia Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 81 Australia Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 82 Australia Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 83 Thailand Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 84 Thailand Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 85 Thailand Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 86 Thailand Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 87 Latin America Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
Table 88 Latin America Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 89 Latin America Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 90 Latin America Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 91 Latin America Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 92 Brazil Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 93 Brazil Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 94 Brazil Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 95 Brazil Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 96 Mexico Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 97 Mexico Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 98 Mexico Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 99 Mexico Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 100 Argentina Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 101 Argentina Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 102 Argentina Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 103 Argentina Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 109 South Africa Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 110 South Africa Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 111 South Africa Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 112 South Africa Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 117 UAE Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 118 UAE Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 119 UAE Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 120 UAE Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 121 Kuwait Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 122 Kuwait Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 123 Kuwait Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 124 Kuwait Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Edema Clinical Trial Market: Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 14 Regional Marketplace: Key Takeaways
Fig. 15 Global Edema Clinical Trial Market for Phase I, 2018 - 2030 (USD Million)
Fig. 16 Global Edema Clinical Trial Market for Phase II, 2018 - 2030 (USD Million)
Fig. 17 Global Edema Clinical Trial Market for Phase III, 2018 - 2030 (USD Million)
Fig. 18 Global Edema Clinical Trial Market for Phase IV, 2018 - 2030 (USD Million)
Fig. 19 Global Edema Clinical Trial Market for Pediatrics , 2018 - 2030 (USD Million)
Fig. 20 Global Edema Clinical Trial Market for Adults, 2018 - 2030 (USD Million)
Fig. 21 Global Edema Clinical Trial Market for Geriatrics, 2018 - 2030 (USD Million)
Fig. 22 Global Edema Clinical Trial Market for Pharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 23 Global Edema Clinical Trial Market for Academic Institutions, 2018 - 2030 (USD Million)
Fig. 24 Global Edema Clinical Trial Market for Government Bodies, 2018 - 2030 (USD Million)
Fig. 25 Global Edema Clinical Trial Market for Systemic Edema, 2018 - 2030 (USD Million)
Fig. 26 Global Edema Clinical Trial Market for Localized Edema, 2018 - 2030 (USD Million)
Fig. 27 Regional Outlook, 2022 & 2030
Fig. 28 North America Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 29 U.S. Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 30 Canada Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 31 Europe Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 32 Germany Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 33 UK Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 34 France Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 35 Italy Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 36 Spain Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 37 Denmark Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 38 Sweden Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 39 Norway Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 40 Asia Pacific Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 41 Japan Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 42 China Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 43 India Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 44 Australia Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 45 South Korea Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 46 Thailand Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 47 Latin America Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 48 Brazil Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 49 Mexico Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 50 Argentina Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 51 Middle East and Africa Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 52 South Africa Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 54 UAE Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 55 Kuwait Edema Clinical Trial Market 2018 - 2030 (USD Million)

★調査レポート[世界の浮腫臨床試験市場2023-2030：フェーズ別（第I相、第II相、第III相、第IV相）、患者別（小児科、成人、高齢者）、スポンサー別、タイプ別、地域別] (コード：GRV23NOV015)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の浮腫臨床試験市場2023-2030：フェーズ別（第I相、第II相、第III相、第IV相）、患者別（小児科、成人、高齢者）、スポンサー別、タイプ別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の浮腫臨床試験市場2023-2030：フェーズ別（フェーズI、フェーズII）、参加者別（小児科、成人）、試験デザイン別（介入試験、観察試験）、種類別（全身性浮腫、局所性浮腫）、地域別
  • 世界の希少疾病治験市場2023-2030：治療領域別（自己免疫・炎症、血液疾患）、フェーズ別（フェーズⅠ、フェーズⅡ、フェーズⅢ）、スポンサー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆